These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


609 related items for PubMed ID: 17981196

  • 1. Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells.
    Sabel MS, Arora A, Su G, Mathiowitz E, Reineke JJ, Chang AE.
    Surgery; 2007 Nov; 142(5):749-60. PubMed ID: 17981196
    [Abstract] [Full Text] [Related]

  • 2. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
    Ye Z, Shi M, Chan T, Sas S, Xu S, Xiang J.
    Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109
    [Abstract] [Full Text] [Related]

  • 3. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC, Conway TF, Sabel MS, Jong YS, Mathiowitz E, Bankert RB, Egilmez NK.
    Cancer Res; 2002 Dec 15; 62(24):7254-63. PubMed ID: 12499267
    [Abstract] [Full Text] [Related]

  • 4. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M, Kjaergaard J, Kuppen PJ, Nannmark U, Agger R, Hokland P, Basse P.
    In Vivo; 1999 Dec 15; 13(3):199-204. PubMed ID: 10459491
    [Abstract] [Full Text] [Related]

  • 5. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 6. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS, Ip G, Wright MA, Young MR.
    Cancer Res; 1995 Feb 15; 55(4):885-90. PubMed ID: 7850804
    [Abstract] [Full Text] [Related]

  • 7. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.
    Tatsumi T, Huang J, Gooding WE, Gambotto A, Robbins PD, Vujanovic NL, Alber SM, Watkins SC, Okada H, Storkus WJ.
    Cancer Res; 2003 Oct 01; 63(19):6378-86. PubMed ID: 14559827
    [Abstract] [Full Text] [Related]

  • 8. Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-alpha in a model of metastatic breast cancer.
    Sabel MS, Su G, Griffith KA, Chang AE.
    Breast Cancer Res Treat; 2010 Jul 01; 122(2):325-36. PubMed ID: 19802695
    [Abstract] [Full Text] [Related]

  • 9. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI, Fuller JA, Kremlev SG, Kamdar SJ, Evans R.
    J Immunol; 1998 Dec 15; 161(12):6977-84. PubMed ID: 9862733
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
    Young MR, Wright MA.
    Cancer Res; 1992 Nov 15; 52(22):6335-40. PubMed ID: 1423279
    [Abstract] [Full Text] [Related]

  • 12. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A, Tzehoval E, Vadai E, Feldman M, Eisenbach L.
    Cancer Res; 1995 Nov 01; 55(21):4941-9. PubMed ID: 7585534
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL, Janssen K, Hao Z, Sondel PM, Yang NS.
    Cancer Gene Ther; 2000 Jun 01; 7(6):826-38. PubMed ID: 10880012
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
    Wu B, Shen RN, Wang WX, Broxmeyer HE, Lu L.
    Stem Cells; 1993 Sep 01; 11(5):412-21. PubMed ID: 8241952
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases.
    Dobrzanski MJ, Reome JB, Dutton RW.
    J Immunol; 1999 Jun 01; 162(11):6671-80. PubMed ID: 10352285
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H.
    J Immunol; 1998 Feb 15; 160(4):1742-9. PubMed ID: 9469432
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
    Comes A, Di Carlo E, Musiani P, Rosso O, Meazza R, Chiodoni C, Colombo MP, Ferrini S.
    Eur J Immunol; 2002 Jul 15; 32(7):1914-23. PubMed ID: 12115611
    [Abstract] [Full Text] [Related]

  • 20. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
    Xiang J, Chen Y, Moyana T.
    Cancer Gene Ther; 2000 Jul 15; 7(7):1023-33. PubMed ID: 10917205
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.